Cargando…

Boosting Immunity in Recipients of Live-Attenuated Zoster Vaccine

Detalles Bibliográficos
Autor principal:	Schmid, D. Scott
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169853/ https://www.ncbi.nlm.nih.gov/pubmed/26452396 http://dx.doi.org/10.1093/infdis/jiv481

Ejemplares similares

Development of antibody-dependent cellular cytotoxicity in response to recombinant and live-attenuated herpes zoster vaccines
por: Park, Seong Yeon, et al.
Publicado: (2022)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)–Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women
por: Perciani, Catia T, et al.
Publicado: (2018)

Evaluation of efficacy and effectiveness of live attenuated zoster vaccine
por: GABUTTI, G., et al.
Publicado: (2014)

Corticosteroids Contribute to Serious Adverse Events Following Live Attenuated Varicella Vaccination and Live Attenuated Zoster Vaccination
por: Price, Nathan B., et al.
Publicado: (2021)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Ageing of Immune System and Response to a Live-Attenuated Herpes Zoster Vaccine in Lung Transplant Candidates
por: Wang, Lei, et al.
Publicado: (2021)

Immune Senescence Factors Associated with the Immunogenicity of a Live Attenuated Zoster Vaccine (ZV) in Older Adults
por: Weinberg, Adriana, et al.
Publicado: (2017)

Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX™) in Korean Adults
por: Choi, Won Suk, et al.
Publicado: (2016)

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
por: Chun, June Young, et al.
Publicado: (2021)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

Risk factors for modified vaccine effectiveness of the live attenuated zoster vaccine among the elderly in England()
por: Bollaerts, Kaatje, et al.
Publicado: (2019)

Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine
por: Litt, John, et al.
Publicado: (2020)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

1075 Effectiveness and Safety of Immunization with Live-attenuated and Inactivated Vaccines for Pediatric Liver Transplantation Recipients
por: Ito, Yoshinori, et al.
Publicado: (2014)

Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine
por: Akpandak, Idara, et al.
Publicado: (2022)

Cellular Immune Response after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
por: Koldehoff, Michael, et al.
Publicado: (2022)

The round trip model for severe herpes zoster caused by live attenuated varicella vaccine virus
por: Grose, Charles, et al.
Publicado: (2020)

The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster
por: Marangi, Luigi, et al.
Publicado: (2017)

Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children
por: Yegorov, Sergey, et al.
Publicado: (2022)

The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study
por: Merzon, Eugene, et al.
Publicado: (2022)

Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020
por: Li-Kim-Moy, Jean, et al.
Publicado: (2023)

Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2022)

Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella
por: Korostil, Igor A, et al.
Publicado: (2015)

Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review
por: Ansaldi, Filippo, et al.
Publicado: (2016)

Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
por: Lee, Eunyoung, et al.
Publicado: (2018)

Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Tylicki, Leszek, et al.
Publicado: (2021)

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-of-Study Results of a Phase III, Group-Matched, Clinical Trial
por: Mrkvan, Tomas, et al.
Publicado: (2018)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial
por: Grupping, Katrijn, et al.
Publicado: (2017)

Zoster vaccine live for the prevention of shingles in the elderly patient
por: Zussman, Jamie, et al.
Publicado: (2008)

Prevention of shingles: safety and efficacy of live zoster vaccine
por: Quan, Dianna, et al.
Publicado: (2007)

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
por: Mohn, Kristin G. I., et al.
Publicado: (2017)

Vaccine immune boost
por: Le Page, Michael
Publicado: (2020)

Clinical Efficacy of Pretransplant Vaccination for Preventing Herpes Zoster After Living Donor Liver Transplantation in Recipients Age 50 Years and Older
por: Cho, Chan Woo, et al.
Publicado: (2019)

Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms
por: Depledge, Daniel P., et al.
Publicado: (2016)

2480. Real-World Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
por: Saddier, Patricia, et al.
Publicado: (2018)

Viral load and antibody boosting following herpes zoster diagnosis
por: Warren-Gash, Charlotte, et al.
Publicado: (2018)

Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines
por: de Boer, Pieter T., et al.
Publicado: (2018)

Reduction in Herpes Zoster Antiviral Use Since the Introduction of the Live-Attenuated Zoster Vaccine on Australia’s National Immunisation Program: A Population-Based Study from 1994 to 2019
por: Phakey, Sachin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3k94jdg5p0d00rh2elf560t9cr